These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 29199716)
1. Pattern of distant metastasis in molecular subtypes of carcinoma breast: An institutional study. Kunikullaya SU; Poddar J; Sharma AD; Patel S Indian J Cancer; 2017; 54(1):327-332. PubMed ID: 29199716 [TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes]. Zhang HM; Zhang BN; Xuan LX; Zhao P Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556 [TBL] [Abstract][Full Text] [Related]
3. Outcomes and recurrence patterns according to breast cancer subtypes in Korean women. Lee Y; Kang E; Lee AS; Baek H; Kim EK; Park SY; Kim JH; Kim YJ; Kim SH; Kim IA; Eom KY; Kim SW Breast Cancer Res Treat; 2015 May; 151(1):183-90. PubMed ID: 25893592 [TBL] [Abstract][Full Text] [Related]
4. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis. Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887 [TBL] [Abstract][Full Text] [Related]
5. Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer. Park HS; Kim S; Kim K; Yoo H; Chae BJ; Bae JS; Song BJ; Jung SS World J Surg Oncol; 2012 Jan; 10():4. PubMed ID: 22226178 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639 [TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognosis analysis of different breast cancer molecular subtypes]. Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463 [TBL] [Abstract][Full Text] [Related]
8. Tumor characteristics and metabolic quantification in carcinoma breast: An institutional experience. Dubey IP; Jain A; Chauhan MS; Kumar R; Agarwal S; Kishore B; Vishnoi MG; Paliwal D; John AR; Kumar N; Sharma A; Pandit AG Indian J Cancer; 2017; 54(1):333-339. PubMed ID: 29199717 [TBL] [Abstract][Full Text] [Related]
9. Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes. Kos T; Aksoy S; Sendur MA; Arik Z; Civelek B; Kandemir N; Ozdemir NY; Zengin N; Altundag K J BUON; 2013; 18(3):608-13. PubMed ID: 24065471 [TBL] [Abstract][Full Text] [Related]
10. Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy. Wong FY; Chin FK; Lee KA; Soong YL; Chua ET Ann Acad Med Singap; 2011 Feb; 40(2):90-6. PubMed ID: 21468463 [TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and prognosis of different subtypes of breast cancer]. Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523 [TBL] [Abstract][Full Text] [Related]
12. [Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes]. Zhang T; Li Q; Xu B; Zhang P; Yuan P; Ma F; Wang J; Fan Y Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):697-702. PubMed ID: 25564062 [TBL] [Abstract][Full Text] [Related]
13. Optimal surveillance for postoperative metastasis in breast cancer patients. Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313 [TBL] [Abstract][Full Text] [Related]
14. Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab. McGuire A; Kalinina O; Holian E; Curran C; Malone CA; McLaughlin R; Lowery A; Brown JAL; Kerin MJ Breast Cancer Res Treat; 2017 Jul; 164(1):221-229. PubMed ID: 28378298 [TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW Breast; 2012 Feb; 21(1):50-7. PubMed ID: 21865043 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer. Inari H; Suganuma N; Kawachi K; Yoshida T; Yamanaka T; Nakamura Y; Yoshihara M; Nakayama H; Masudo K; Oshima T; Yokose T; Rino Y; Shimizu S; Miyagi Y; Masuda M Breast Cancer; 2017 Nov; 24(6):748-755. PubMed ID: 28425014 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696 [TBL] [Abstract][Full Text] [Related]
18. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M; Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648 [TBL] [Abstract][Full Text] [Related]
19. Molecular subtypes of breast carcinoma in Egyptian women: clinicopathological features. El-Hawary AK; Abbas AS; Elsayed AA; Zalata KR Pathol Res Pract; 2012 Jul; 208(7):382-6. PubMed ID: 22641056 [TBL] [Abstract][Full Text] [Related]
20. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]